The Neural Mechanism of Respiratory Allergies and Infections
呼吸道过敏和感染的神经机制
基本信息
- 批准号:10612424
- 负责人:
- 金额:$ 51.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-14 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAcuteAddressAfferent NeuronsAirAllergensAllergicAllergic rhinitisAntihistaminesAttenuatedAxonBasic ScienceBehaviorBehavioralBrain StemBurning PainCalciumCapsaicinCell DegranulationCellsChemicalsChili PepperChronicClinicalClinical ResearchCommon CoreDefense MechanismsDetectionDevelopmentEnvironmental IrritantsEsthesiaFiberG-Protein-Coupled ReceptorsGeneticHistamineHumanHypersensitivityIgEImaging DeviceImmuneImmunologicsInfectionIrritantsLabelLightLungMediatingMediatorModelingMucous MembraneMusNeuroimmuneNeuronsNosePathologicPatternPhysiologicalPilot ProjectsPlayPopulationProductivityPropertyPruritusQuality of lifeReflex actionRespirationRoleSensorySignal TransductionSneezingStimulusStructure of mucous membrane of noseStructure of trigeminal ganglionSymptomsTestingTherapeuticWild Type Mouseaerosolizedcholinergicdesigner receptors exclusively activated by designer drugsfiber cellgenetic approachimaging approachinsightmast cellnerve supplyneuromechanismneuropeptide FFneurotransmissionnew therapeutic targetnovelnovel therapeuticspathogenpharmacologicpreventresponsesensory stimulussymptomatology
项目摘要
Abstract
Allergic rhinitis is the most common mucosal allergy. Its cardinal symptoms include excessive sneezing
and rhinorrhea, which severely impact our life quality and productivity. Although antihistamines effectively
relieved sneezing induced by intermittent mild allergic rhinitis, they are ineffective against persistent
moderate/severe allergic rhinitis. The development of new drugs for alleviating allergic sneezing is hindered by
a lack of information about the principal nasal sensory neurons that mediate sneezing and their interactions with
immune cells. In this proposal, we hypothesize that a highly restricted population of nasal sensory neurons
defined by the expression of MrgprC11 detect mast cell mediators in allergic rhinitis and trigger the sneezing
reflex. In Aim 1, we will characterize the innervation pattern of MrgprC11-expressing fibers in the nasal mucosa
and examine their pathological changes under allergic rhinitis using genetic labeling and axonal tracing
approaches. Furthermore, we will determine their physiological responses to a variety of sneeze-inducing
molecules using a novel ex vivo calcium-imaging tool. These studies will provide important information on the
initial detection of nasal irritants and transduction of sneezing signals. In Aim 2, we will define the role of
MrgprC11+ fibers in acute sneezing. We will determine whether ablation of MrgprC11+ neurons attenuates
sneezing responses to a variety of nasal irritants and whether selective activation of MrgprC11+ sensory fibers
in the nasal mucosa evokes sneezing. These studies will establish whether MrgprC11+ sensory fibers are
required for sneezing induced by different sensory stimuli. In Aim 3, we will investigate the neuro-immune
interactions between MrgprC11+ nasal sensory fibers and mast cells in allergic rhinitis. We will test whether
degranulated mast cells activate MrgprC11+ nasal sensory fibers to induce sneezing in allergic rhinitis.
Furthermore, we will determine whether pharmacological silencing of MrgprC11+ sensory fibers is a feasible
therapeutic strategy to control sneezing associated with allergic rhinitis. These studies will not only advance our
understanding of the neuro-immune interactions that trigger sneezing, but also provide a novel neuronal target
for controlling nasal allergic symptoms.
抽象的
过敏性鼻炎是最常见的粘膜过敏。它的主要症状包括过度打喷嚏
和Rhinorrhea,这严重影响了我们的生活质量和生产力。尽管有效地抗组胺药
间歇性轻度过敏性鼻炎引起的释放的打喷嚏,对持续性无效
中度/严重的过敏性鼻炎。减轻过敏性打喷嚏的新药的开发受到了阻碍
缺乏有关介导打喷嚏及其与其相互作用的主要鼻感官神经元的信息
免疫细胞。在此提案中,我们假设鼻感觉神经元受到严格限制
由MRGPRC11的表达定义
反射。在AIM 1中,我们将表征鼻粘膜表达MRGPRC11的神经模式
并使用遗传标记和轴突追踪检查其在过敏性鼻炎下的病理变化
方法。此外,我们将确定他们对各种打喷嚏的生理反应
使用新型的离体钙成像工具的分子。这些研究将提供有关
初始检测鼻刺激物和打喷嚏信号的转导。在AIM 2中,我们将定义
MRGPRC11+急性打喷嚏的纤维。我们将确定消融MRGPRC11+神经元是否减弱
对各种鼻刺激物的打喷嚏反应以及MRGPRC11+感觉纤维的选择性激活是否是否
在鼻粘膜中,唤起打喷嚏。这些研究将确定MRGPRC11+感觉纤维是否是
由不同的感觉刺激引起的打喷嚏所必需的。在AIM 3中,我们将研究神经免疫
MRGPRC11+鼻感觉纤维与肥大细胞之间的相互作用。我们将测试是否
脱粒的肥大细胞激活MRGPRC11+鼻感觉纤维,以诱导过敏性鼻炎打喷嚏。
此外,我们将确定MRGPRC11+感觉纤维的药理沉默是否是可行的
控制与过敏性鼻炎相关的打喷嚏的治疗策略。这些研究不仅会推动我们的
了解引发打喷嚏的神经免疫相互作用,但也提供了一种新型的神经元靶标
用于控制鼻过敏症状。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Qin Liu其他文献
Qin Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Qin Liu', 18)}}的其他基金
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases
基于 CRISPR/Cas9 的基因编辑方法用于治疗 USH2A 相关疾病
- 批准号:
10626831 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases
基于 CRISPR/Cas9 的基因编辑方法用于治疗 USH2A 相关疾病
- 批准号:
10446571 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
The Neural Mechanism of Respiratory Allergies and Infections
呼吸道过敏和感染的神经机制
- 批准号:
10405559 - 财政年份:2021
- 资助金额:
$ 51.71万 - 项目类别:
The Neural Mechanism of Respiratory Allergies and Infections
呼吸道过敏和感染的神经机制
- 批准号:
10279722 - 财政年份:2021
- 资助金额:
$ 51.71万 - 项目类别:
HISTAMINE-INDEPENDENT MAST CELL NERVE INTERACTIONS IN ALLERGY
过敏中不依赖组胺的肥大细胞神经相互作用
- 批准号:
9160145 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
整合外周血生物标志物特征用于肺癌的诊断、预后、缓解和复发
- 批准号:
9904543 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
HISTAMINE-INDEPENDENT MAST CELL NERVE INTERACTIONS IN ALLERGY
过敏中不依赖组胺的肥大细胞神经相互作用
- 批准号:
9908041 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
整合外周血生物标志物特征用于肺癌的诊断、预后、缓解和复发
- 批准号:
10376913 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
HISTAMINE-INDEPENDENT MAST CELL NERVE INTERACTIONS IN ALLERGY
过敏中不依赖组胺的肥大细胞神经相互作用
- 批准号:
9272358 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 51.71万 - 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
- 批准号:
10719459 - 财政年份:2023
- 资助金额:
$ 51.71万 - 项目类别:
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 51.71万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 51.71万 - 项目类别:
Investigating cerebrovascular dysfunction and cerebral atrophy in severe traumatic brain injury
严重颅脑损伤中脑血管功能障碍和脑萎缩的调查
- 批准号:
10742569 - 财政年份:2023
- 资助金额:
$ 51.71万 - 项目类别: